UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
IEEE transactions on information theory, ISSN 0018-9448, 2012, Volume 58, Issue 7, pp. 4381 - 4395
Journal Article
International journal of pure and applied mathematics : IJPAM, ISSN 1311-8080, 2018, Volume 119, Issue 15, pp. 2131 - 2141
Journal Article
Nature communications, ISSN 2041-1723, 12/2020, Volume 11, Issue 1, pp. 1620 - 1620
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Broadly Neutralizing Antibodies - immunology | SARS Virus - immunology | Pandemics | Calcium Channels - metabolism | Receptors, Virus - metabolism | Humans | Protein Multimerization | Severe Acute Respiratory Syndrome - immunology | Neutralization Tests | Cathepsin L - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Virus Internalization | Betacoronavirus - immunology | COVID-19 | Cell Fusion | Endocytosis | SARS-CoV-2 | Betacoronavirus - chemistry | Betacoronavirus - physiology | HEK293 Cells | Peptidyl-Dipeptidase A - metabolism | Giant Cells - physiology | Protein Domains | Spike Glycoprotein, Coronavirus - immunology | Cathepsins - antagonists & inhibitors | Spike Glycoprotein, Coronavirus - metabolism | Trypsin - metabolism | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | Cross Reactions | Angiotensin-Converting Enzyme 2 | Cathepsins - metabolism | Antibodies, Viral - immunology | Spike Glycoprotein, Coronavirus - chemistry | Cathepsin L | Spike protein | Cross-reactivity | Severe acute respiratory syndrome | Viral diseases | Antibodies | Viruses | Glycoproteins | Vaccines | Coronaviruses | Drug development | Angiotensin-converting enzyme 2--ACE2 | Immunosuppressive agents | Severe acute respiratory syndrome coronavirus 2 | Proteins | Angiotensin | Spike glycoprotein | Neutralization | Index Medicus
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 07/2020, Volume 26, Issue 7, pp. 1478 - 1488
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Pandemics | Enzyme-Linked Immunosorbent Assay | COVID-19 Testing | Coronavirus Infections - diagnosis | Humans | Neutralization Tests | Antibodies, Viral - blood | Betacoronavirus - immunology | COVID-19 | Clinical Laboratory Techniques - methods | SARS-CoV-2 | Sensitivity and Specificity | Pneumonia, Viral - diagnosis | Serologic Tests | Medical research | Severe acute respiratory syndrome | Immunoglobulin G | Medicine, Experimental | Coronaviruses | Immunoglobulin A | Health aspects | Enzyme-linked immunosorbent assay | Pathogens | Antigens | Blood & organ donations | Laboratories | Antibodies | Viruses | Infections | Blood banks | Patients | Middle East respiratory syndrome | Severe acute respiratory syndrome coronavirus 2 | Proteins | Respiratory diseases | Index Medicus | viruses | human coronavirus | Expedited | HCoV | Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease 2019 Patients | neutralization | spike protein | receptor-binding domain | coronavirus | zoonoses | Research | respiratory infections | RBD | coronavirus disease 2019 | nucleocapsid protein | antibodies | serologic analysis | ELISA | 2019 novel coronavirus disease
Journal Article
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 23, pp. 3082 - 3088
Allergy and Immunology | Assay | Antibodies | Vaccine | Respiratory syncytial virus | International standard | Neutralization | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Neutralization Tests - standards | Laboratories | Humans | Intersectoral Collaboration | Neutralization Tests - instrumentation | Antibodies, Viral - blood | Antibodies, Viral - isolation & purification | Antibodies, Neutralizing - isolation & purification | Reference Standards | Animals | Internationality | Respiratory Syncytial Virus, Human - immunology | Neutralization Tests - methods | Antibodies, Neutralizing - blood | Virus diseases | Viral antibodies | Medical research | Analysis | Medicine, Experimental | Health aspects | Biotechnology | Candidates | Immunoglobulins | Statistical analysis | Research & development--R&D | Mortality | Feasibility studies | Viruses | Infections | Statistical methods | Vaccines | Assaying | Disease prevention | Studies | Illnesses | Immunogenicity | Neutralizing | Respiratory diseases | Cell lines | Index Medicus | NI, Natural infection | CT, Clinical trial | IS, International standard
Journal Article
Hydrometallurgy, ISSN 0304-386X, 2011, Volume 108, Issue 1, pp. 60 - 79
Bauxite residue management | Bauxite residue | Bauxite residue neutralization | Buffering chemistry | Surface charge | Red mud | Alkaline solids | Bauxite residue disposal | Bauxite residue utilization | Technology | Metallurgy & Metallurgical Engineering | Science & Technology | Applied sciences | Metals. Metallurgy | Production of metals | Exact sciences and technology | Aluminum base alloys | Residues | Bauxite | Bayer process | Byproducts | Alkalinity | Environmental impact
Journal Article
Parasites & vectors, ISSN 1756-3305, 2014, Volume 7, Issue 1, pp. 476 - 476
Mediterranean basin | Bunyaviridae | Dogs | Emerging | Toscana virus | Sand flies | Phleboviruses | Sentinels | Dog Diseases - epidemiology | Bunyaviridae Infections - veterinary | Antigens, Viral - genetics | Seroepidemiologic Studies | Psychodidae - virology | Sandfly fever Naples virus - genetics | Animals | Bunyaviridae Infections - virology | Neutralization Tests - veterinary | Neutralization Tests - methods | Bunyaviridae Infections - epidemiology | Phlebovirus - genetics | Dog Diseases - virology | Tunisia - epidemiology | Leishmaniasis | Research | Studies | Viruses | Infections | Zoonoses | Index Medicus | Tunisia/epidemiology | Bunyaviridae Infections/epidemiology | Psychodidae/virology | Bunyaviridae Infections/virology | Antigens, Viral/genetics | Phlebovirus/genetics | Life Sciences | Microbiology and Parasitology | Dog Diseases/epidemiology | Neutralization Tests/veterinary | Santé publique et épidémiologie | Bunyaviridae Infections/veterinary | Neutralization Tests/methods | Sandfly fever Naples virus/genetics | Dog Diseases/virology
Journal Article
Journal of virology, ISSN 0022-538X, 05/2017, Volume 91, Issue 9
HIV-1 envelope (Env) | Virological synapse (VS) | Tyrosine-based sorting motif | Incomplete neutralization | Efficacy | Human immunodeficiency virus subtype 1 (HIV-1) | Potency | Broadly neutralizing antibodies (bNAbs) | Maximum neutralization | Cell-to-cell infection | env Gene Products, Human Immunodeficiency Virus - immunology | Jurkat Cells | HIV Infections - virology | Humans | Neutralization Tests | CD4-Positive T-Lymphocytes - immunology | Epitopes - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | HIV Antibodies - immunology | HEK293 Cells | Cell Line, Tumor | HIV Infections - transmission | CD4-Positive T-Lymphocytes - virology | Index Medicus
Journal Article
Nature (London), ISSN 0028-0836, 08/2020, Volume 584, Issue 7821, pp. 437 - 442
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Coronavirus Infections - prevention & control | Antibodies, Neutralizing - analysis | Antibody Specificity | Pandemics | Humans | Middle Aged | Male | Neutralization Tests | Betacoronavirus - immunology | COVID-19 | Young Adult | Antibodies, Neutralizing - immunology | SARS-CoV-2 | Antibodies, Monoclonal - analysis | Antibodies, Viral - analysis | Adult | Female | Spike Glycoprotein, Coronavirus - immunology | Antibodies, Monoclonal - immunology | Enzyme-Linked Immunosorbent Assay | Coronavirus Infections - immunology | Pneumonia, Viral - immunology | COVID-19 Vaccines | Adolescent | Antibodies, Viral - immunology | Aged | Spike Glycoprotein, Coronavirus - chemistry | Viral Vaccines - immunology | Viral antibodies | Antibodies | Research | Therapeutics, Experimental | Epidemics | New York | Antiviral agents | Severe acute respiratory syndrome | B cells | Coronaviruses | Vaccines | Health aspects | Plasma | Viral diseases | Viruses | Infections | Asymptomatic | Antibody response | Antiviral activity | Standard deviation | Age | Women | Antigens | Signs and symptoms | Immunological memory | Memory cells | Hospitalization | Epitopes | Severe acute respiratory syndrome coronavirus 2 | Lymphocytes B | Neutralizing | Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2009, Volume 27, Issue 48, pp. 6777 - 6790
Allergy and Immunology | Pseudotype-based neutralization assay | Neutralizing antibodies | HPAI H5N1 virus | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Fundamental and applied biological sciences. Psychology | Miscellaneous | Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) | Microbiology | Applied microbiology | Biological and medical sciences | Virology | Orthomyxoviridae Infections - prevention & control | Virus Release | Influenza A Virus, H5N1 Subtype - physiology | Viral Proteins - immunology | Neuraminidase - genetics | Influenza A Virus, H5N1 Subtype - genetics | Hemagglutinin Glycoproteins, Influenza Virus - immunology | Antibodies, Viral - blood | Virus Internalization | Neuraminidase - immunology | Antibodies, Neutralizing - immunology | Sensitivity and Specificity | Female | Neutralization Tests - methods | Cell Line | Hemagglutinins, Viral - genetics | Viral Proteins - genetics | Ferrets | Hemagglutinins, Viral - immunology | Animals | Influenza Vaccines - immunology | Influenza A Virus, H5N1 Subtype - immunology | Dogs | Antibodies, Viral - immunology | Mice | Mice, Inbred BALB C | Antibodies, Neutralizing - blood | Orthomyxoviridae Infections - immunology | Virus diseases | Measurement | Avian influenza | Influenza viruses | Antiviral agents | Integrated logistic support | Luciferase | Lectins | Nucleic acids | Health aspects | Biosafety | Viruses | Infections | Vaccines | Swine flu | Plasmids | Index Medicus | Antibodies, Neutralizing | Neutralization Tests | Viral Proteins | Influenza A Virus, H5N1 Subtype | Antibodies, Viral | Hemagglutinin Glycoproteins, Influenza Virus | Life Sciences | Microbiology and Parasitology | Neuraminidase | Hemagglutinins, Viral | Influenza Vaccines | Orthomyxoviridae Infections | NA, neuraminidase | PN, pseudotype-based neutralization | HA, hemagglutinin | MN, microneutralization | HPAI, highly pathogenic avian influenza | RLA, relative luciferase activity | HI, hemagglutination inhibition
Journal Article